Endexx Corporation Investor Newsletter

Dear Valued Shareholders and Stakeholders,

As Endexx Corporation transitions toward a pivotal rebranding to HYLA, we are excited to share insights into our strategic developments and financial growth that underscore our commitment to innovation and market expansion.

A Year of Significant Growth and Strategic Partnerships

Over the past year, Endexx Corporation has achieved remarkable financial growth, with our revenues soaring to $3,908,385—an 83% increase compared to the previous year. This surge is a testament to the robust demand for our plant-based lifestyle products and the effectiveness of our targeted market strategies.

Our expansion into global markets has been particularly notable. Italy now represents 48% of our total revenues, evidencing the strong appeal of our products in the European market. Additionally, consistent performances in the U.S. and Northern Eurasia have solidified our presence on the international stage, demonstrating our ability to adapt and thrive in diverse markets.

Strategic Developments and Forward-Looking Initiatives

As we evolve from Endexx Corporation to HYLA, we're not just changing our name—we're setting the stage for a new era of growth. This strategic shift is more than a rebranding; it's a fundamental transformation aimed at positioning ourselves at the forefront of the wellness industry.

This transformation is already gaining momentum with significant new partnerships, notably a groundbreaking distribution agreement with a premier distributor in Houston, Texas. This deal, totaling $348,812.50, is not just a transaction; it's the start of what we expect to be a flourishing partnership that will greatly enhance our distribution capabilities and increase our market reach in the United States.

Nick Mehdi, CEO of HYLA, expressed his enthusiasm about this partnership: "This landmark transaction cements our market dominance and lays the foundation for scalable growth and intensified market presence. We are poised to redefine wellness standards with HYLA’s innovative non-nicotine, guarana, and L-Dopa-based products."

Financial Stewardship and Enhanced Shareholder Engagement

Our financial strategy remains as disciplined as it is ambitious. We've strategically managed our financial obligations, with approximately $10.14 million in notes payable carefully balanced between short-term needs and long-term growth objectives. This financial prudence ensures we maintain operational flexibility to support significant orders and sustain our growth trajectory.

Looking ahead, we are committed to enhancing our engagement with you, our shareholders, through more frequent updates and detailed guidance on our progress. We plan to increase our public relations efforts and host shareholder meetings to provide deeper insights into our strategies and operations.

Conclusion: A Future of Prosperity and Innovation

We are on an exciting path toward becoming HYLA, a symbol of innovation and environmental stewardship in the wellness industry. With strong financial foundations and strategic partnerships, we are poised to seize emerging market opportunities and drive substantial growth.

Thank you for your continued trust and support. We are enthusiastic about our future and look forward to achieving new heights together.

Warm regards,

Brad Listermann (Click for my resume)

Management Consultant

Endexx Corporation

Legal Disclaimer: This newsletter is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. All information presented here is derived from previously filed financial statements and publicly released press information; no new disclosures are included. Please consider all associated risks and consult with an independent financial advisor.